PGY2 Oncology

The PGY2 Oncology Pharmacy Residency Program at MMC is a 12-month, advanced training program designed to transition PGY1 pharmacy practice residency graduates from general practice to a specialized practice focused on the care of patients with cancer. This advanced program at MMC has a focus on adult patients with cancer, with an emphasis on supportive care, antineoplastic pharmacology, management of malignant and hematological disorders, investigational cancer therapies, and antineoplastic toxicity management. Graduates from the program will be equipped to serve as integral members of interdisciplinary teams caring for individuals with cancers in both inpatient and outpatient settings.

Core

  • Anticoagulation
  • Gynecological Oncology
  • Infusion Practice Management
  • Inpatient Oncology
  • Investigational Drugs
  • Oncology Infectious Diseases
  • Outpatient Medical Oncology
  • Pediatric Oncology (Inpatient/Outpatient)

Elective

  • Advanced Core
  • Bone Marrow Transplant
  • Genetics

Longitudinal

  • Academia
  • Committee Involvement
  • Community Outreach
  • Guideline/Protocol Development
  • Medication Use Evaluation
  • Research Project
  • Pharmacy Operations- (Inpatient/Outpatient Staffing)